International Patent: HUMANIZED NANOBODY TARGETING HUMAN CD19 AND USE THEREOF

GENEVA, Oct. 30 -- ANOBIOMED INC filed a patent application (CN2026/091602) for “HUMANIZED NANOBODY TARGETING HUMAN CD19 AND USE THEREOF”. With publication no. WO/2026/223549, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....